查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2089801

胰島素幫浦市場規模、佔有率和趨勢分析報告：按產品、系統結構、最終用途、地區和細分市場分類（2026-2033 年）

Insulin Pump Market Size, Share & Trends Analysis Report By Product (Tubed Pump, Tubeless Insulin Pump), By System Architecture (Open-loop, Closed-Loop), By End Use (Hospitals & Care Providers, Homecare), By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10個工作天內

價格

胰島素幫浦市場概述

全球胰島素幫浦市場預計到 2025 年將達到 72 億美元，到 2026 年將成長至 78 億美元，到 2033 年將達到 131 億美元，2026 年至 2033 年的複合年成長率為 7.8%。

預計到2025年，北美胰島素幫浦市場將佔據全球市場最大佔有率，達到45.4%。市場擴張的主要促進因素是老年人口成長、糖尿病發生率上升和肥胖症盛行率增加。

各公司正在研發配備先進技術的下一代胰島素泵，以提高治療依從性並增強與資訊技術的整合，從而推動市場進一步成長。家庭輸注療法和人工胰臟技術等創新預計將在不久的將來創造巨大的成長機會。此外，隨著胰島素幫浦的普及，已開發市場和開發中國家市場都在不斷擴大。人口老化、肥胖和不健康的生活方式導致糖尿病發病率不斷上升，這是推動市場成長的因素之一。肥胖是糖尿病的主要誘因，並會導致糖尿病相關眼科疾病發生率的增加。肥胖、吸菸和高膽固醇等風險因素預計將增加第二型糖尿病的盛行率。世界衛生組織（WHO）的最新全球預測表明，如果目前的趨勢持續下去，到2050年，全球超過一半的成年人口（約38億人）可能會超重或肥胖。

此外，易患糖尿病神經病變病變的老年人數量正在顯著增加。老年人由於糖尿病病程較長、神經再生能力下降以及合併其他疾病等因素，更容易罹患糖尿病神經病變，這些因素都會加重神經病變的症狀。隨著全球人口老化，世界衛生組織（世衛組織）預測，到2030年，全球六分之一的人口將達到或超過60歲，這一數字已從2020年的10億增加到近期的14億。預計到2050年，全球60歲及以上人口將加倍，達到21億，而80歲及以上人口預計將成長兩倍，達到4.26億。這些人口結構變化增加了糖尿病和周邊神經病變等慢性疾病的機率，增加了老年人糖尿病神經病變的風險。

胰島素幫浦產業的成長預計將受到技術進步和製造商在關鍵應用領域產品核可競爭的推動。隨著越來越多的公司獲得FDA批准，其普及率正在顯著提高。例如，2023年4月，FDA批准了Medtronic的MiniMed 780G系統，這是一款適用於7歲及以上第一型糖尿病患者的先進自動化胰島素輸注系統。這是全球首款採用餐前檢測技術的胰島素幫浦。該系統利用持續血糖監測（CGM）追蹤血糖值，並自動調整胰島素劑量。它由血糖感測器、無線數據傳輸裝置和智慧胰島素幫浦組成。臨床試驗和真實世界數據已證實其在糖尿病管理中的安全性和有效性，能夠改善使用者的血糖控制和生活品質。隨著胰島素幫浦市場的擴張，以及血糖控制改善和生活品質提升等益處，胰島素幫浦可望顯著提高糖尿病患者的獨立性，並幫助他們擁有更健康、更充實的生活方式。

“用餐時間是 1 型糖尿病患者面臨的最大挑戰之一，但 MiniMed 780G 系統憑藉其自動、即時的胰島素校正功能，首次滿足了這一未被滿足的需求。”

Medtronic力公司關鍵負責人

各國政府主導的旨在提高全球對醫療保健政策和糖尿病管理意識的舉措日益增多，也推動了市場成長。此外，醫療保健成本的上升以及對更先進、更隱密、更易用的無導管胰島素幫浦日益成長的需求，也是促成市場成長的因素。預計這些因素將在預測期內推動市場成長。

“我們推出這項獨特的社區競賽，旨在更深入地了解患者如何用自己的語言描述糖尿病神經病變。”

透過用患者自己的語言重新定義症狀，我們旨在幫助糖尿病周邊神經病變患者和醫療保健專業人員使用通用的語言來交流他們的症狀，從而促進關於診斷、疾病管理和潛在解決方案的更有效的對話。

Lizandra Malcondes 博士，Averitas 製藥醫療事務主管

先進技術和創新技術的融合旨在改善患者療效，從而推動市場成長。近期發展包括封閉回路型系統的研發，該系統通常被稱為“人工胰腺系統”，它能夠根據即時血糖值監測自動輸注胰島素。胰島素幫浦與持續血糖監測 (CGM) 技術的無縫整合以及其在血糖控制方面的顯著療效，使其成為對抗糖尿病的重要工具。將胰島素幫浦與自動胰島素輸注 (AID) 系統、可連接的胰島素筆和智慧筆蓋結合的系統，進一步提升了糖尿病管理水平。結合高性能持續血糖監測 (CGM) 感測器，該技術能夠實現精準高效的血糖控制。此外，無線連接和與行動應用程式的整合，實現了無縫的數據追蹤和遠端監測，為醫療專業人員提供了寶貴的患者管理資訊。胰島素幫浦設計的進步，例如更小巧、更隱密的設備和無痛插入技術，正在提高患者的舒適度和治療依從性。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：胰島素幫浦市場：影響因素、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 胰島素幫浦市場分析工具

第4章：胰島素幫浦市場：產品具體估算與趨勢分析

  • 胰島素幫浦市場：產品特定波動分析
  • 胰島素幫浦市場：產品展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 管式幫浦
  • 無管胰島素泵

第5章：胰島素幫浦市場：系統結構的估算與趨勢分析

  • 胰島素幫浦市場：按系統結構的波動分析
  • 胰島素幫浦市場：按系統結構的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 開放回路系統
  • 封閉回路型系統

第6章：胰島素幫浦市場：依最終用途分類的估算與趨勢分析

  • 胰島素幫浦市場：按最終用途分類的波動分析
  • 胰島素幫浦市場：按最終用途分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 居家照護
  • 醫院和護理機構

第7章 胰島素幫浦市場：區域估算與趨勢分析

  • 區域儀錶板
  • 區域胰島素幫浦市場波動分析
  • 胰島素幫浦市場：區域預測與趨勢分析
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
    • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 參與企業的分類
  • 企業市場占有率分析，2025 年
  • 主要公司簡介
    • Medtronic
    • F. Hoffmann-La Roche AG
    • Tandem Diabetes Care, Inc.
    • Insulet Corporation
    • Ypsomed
    • Sanofi SA
    • Sooil development
    • Jiangsu Delfu Co., Ltd.
    • Cellnovo Ltd
    • Valeritas, Inc
Product Code: GVR-3-68038-876-3

Insulin Pump Market Summary

The global insulin pump market size was valued at USD 7.2 billion in 2025 and is projected to grow from USD 7.8 billion in 2026 to USD 13.1 billion by 2033, growing at a CAGR of 7.8% from 2026 to 2033. North America insulin pump market held the largest share of 45.4% of the global market in 2025. The market expansion is primarily driven by the growing elderly population, rising diabetes incidence, and increasing obesity prevalence.

Companies are developing next-generation insulin pumps with advanced technology to enhance compliance and integration with IT devices, further driving market growth. Innovations such as home infusion therapy and artificial pancreas technology are expected to create significant growth opportunities in the near future. Additionally, as insulin pumps gain popularity, markets in both developed and developing countries are expanding. An increase in the incidence of diabetes due to aging, obesity, and an unhealthy lifestyle is one of the factors contributing to the growth of the market. Obesity is a major factor causing diabetes, leading to increased incidences of diabetes-associated ophthalmic disorders. Risk factors, such as obesity, smoking, and high cholesterol, are expected to boost the prevalence of type II diabetes. According to the World Health Organization (WHO), recent global projections indicate that more than half of the world's adult population (approximately 3.8 billion people) could be living with overweight or obesity by 2050 if current trends continue.

Furthermore, there is a notable increase in the number of elderly individuals prone to developing diabetic neuropathy. The geriatric demographic is particularly vulnerable due to factors such as longer diabetes duration, decreased nerve regeneration capacity, and comorbidities that can exacerbate neuropathic symptoms. As the global population ages, the World Health Organization (WHO) predicts that the number of people aged 60 years and older will increase to 1 in 6 by 2030, rising from 1 billion in 2020 to 1.4 billion recently. The global population of people aged 60 years and older is expected to double to 2.1 billion by 2050, with individuals aged 80 years or older set to triple to 426 million. This demographic shift will lead to a higher likelihood of chronic conditions like diabetes and peripheral neuropathy, increasing the risk of diabetic neuropathy among seniors.

The insulin pump industry growth is anticipated to be driven by the technological advancements and manufacturers competing for product approval in key application area drives the market forwards. As more companies receive FDA approval, their adoption has notably increased. For instance, in April 2023, the FDA approved the Medtronic MiniMed 780G System, an advanced automated insulin delivery system for individuals aged 7 and older with type 1 diabetes. It is the world's first insulin pump with 'Meal Detection Technology'. This system uses continuous glucose monitoring (CGM) to track glucose levels and automatically adjusts insulin delivery. It includes a glucose sensor, wireless data transmission, and a smart insulin pump. Clinical trials and real-world evidence confirm its safety and effectiveness in managing diabetes, enhancing users' glucose control and quality of life. With the anticipated expansion of the insulin pump market and supported benefits such as better blood sugar control and improved quality of life, insulin pumps are poised to significantly empower individuals with diabetes, leading to healthier and more satisfying lifestyles.

"Mealtimes prove to be one of the biggest challenges for people living with type 1 diabetes and now for the first time, the MiniMed 780G system addresses this unmet need with automatic, real-time insulin corrections"

Key Professional at Medtronic plc

Increasing government initiatives for global awareness about medicare policies and the management of diabetes are also fueling market growth. Furthermore, there has been a rise in healthcare spending and an increase in the demand for improved tubeless insulin pumps that are both discreet and user-friendly. This is expected to drive market growth during the forecast period.

"We launched this unique contest in the community to better understand how patients describe diabetic nerve pain of their feet in their own terms.

By redefining the symptoms using their own words, our goal is to help diabetic peripheral neuropathy patients and their health care providers start using common language to talk about their symptoms, fostering more productive conversations around diagnosis, disease management and potential solutions."

Dr. Lizandra Marcondes, Head Medical Affairs Averitas Pharma

Innovations in integrating advanced technology and improving patient outcomes is driving market growth. The latest developments include the creation of closed-loop systems, also known as artificial pancreas systems, which automate insulin delivery based on real-time glucose monitoring. With their seamless integration with continuous glucose monitoring (CGM) technology and demonstrated effectiveness in blood sugar management, insulin pumps are becoming essential tools in the fight against diabetes. Systems such as a pump connected to an automated insulin delivery (AID) system, paired with a connected insulin pen or smart pen cap, enhance diabetes management. When combined with a powerful continuous glucose monitor (CGM) sensor, this technology offers precise and efficient blood glucose control. Further, the incorporation of wireless connectivity and mobile app integration allows for seamless data tracking and remote monitoring, providing healthcare providers with valuable insights into patient management. Moreover, advancements in pump design, such as smaller, more discreet devices and pain-free insertion techniques, are increasing patient comfort and adherence.

Global Insulin Pump Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global insulin pump market report on the basis of product, system architecture, end use and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Tubed Pump
  • Tubeless Insulin Pump
  • System Architecture Outlook (Revenue, USD Million, 2021 - 2033)
  • Open-loop Systems
  • Closed-loop Systems
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Homecare
  • Hospitals & Care Providers
  • Region Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. System Architecture
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Insulin Pump Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. High prevalence of diabetes and associated disorders
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Increasing adoption of insulin pumps
      • 3.2.1.4. Increase in number of product approvals
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High-cost barriers
      • 3.2.2.2. Stringent regulatory approvals
  • 3.3. Insulin Pump Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Insulin Pump Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Insulin Pump Market: Product Movement Analysis
  • 4.3. Insulin Pump Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Tubed Pump
    • 4.5.1. Tubed Pump Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Tubeless Insulin Pump
    • 4.6.1. Tubeless Insulin Pump Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Insulin Pump Market: System Architecture Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Insulin Pump Market: System Architecture Movement Analysis
  • 5.3. Insulin Pump Market by System Architecture Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Open-loop Systems
    • 5.5.1. Open-loop Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Closed-loop Systems
    • 5.6.1. Closed-loop Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Insulin Pump Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Insulin Pump Market: End-use Movement Analysis
  • 6.3. Insulin Pump Market by End-use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Homecare
    • 6.5.1. Homecare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Hospitals & Care Providers
    • 6.6.1. Hospitals & Care Providers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Insulin Pump Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Insulin Pump Market Movement Analysis
  • 7.3. Insulin Pump Market: Regional Estimates & Trend Analysis by Product & End-Use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. North America
    • 7.5.1. North America Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. U.S. Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. Canada Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Scenario
      • 7.5.4.5. Mexico Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement Scenario
      • 7.5.7.5. UK Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement Scenario
      • 7.5.8.5. Germany Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement Scenario
      • 7.5.9.5. France Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement Scenario
      • 7.5.10.5. Italy Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement Scenario
      • 7.5.11.5. Spain Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement Scenario
      • 7.5.12.5. Denmark Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement Scenario
      • 7.5.13.5. Sweden Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement Scenario
      • 7.5.14.5. Norway Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Japan Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. China Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Scenario
      • 7.6.4.5. India Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Scenario
      • 7.6.5.5. South Korea Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement Scenario
      • 7.6.6.5. Australia Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement Scenario
      • 7.6.7.5. Thailand Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Scenario
      • 7.7.2.5. Brazil Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Scenario
      • 7.7.3.5. Argentina Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Scenario
      • 7.8.2.5. South Africa Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Scenario
      • 7.8.3.5. Saudi Arabia Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Scenario
      • 7.8.4.5. UAE Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Scenario
      • 7.8.5.5. Kuwait Insulin Pump Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Share Analysis, 2025
  • 8.3. Key Company Profiles
    • 8.3.1. Medtronic
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. F. Hoffmann-La Roche AG
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Tandem Diabetes Care, Inc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Insulet Corporation
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Ypsomed
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Sanofi S.A.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Sooil development
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Jiangsu Delfu Co., Ltd.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Cellnovo Ltd
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Valeritas, Inc
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 4 Global insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 5 Global Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 6 North America insulin pump market, by region, 2021 - 2033 (USD Million)
  • Table 7 North America Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 8 North America insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 9 North America Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 10 U.S. Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 11 U.S. insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 12 U.S Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 13 Canada Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 14 Canada insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 15 Canada Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 16 Mexico Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 17 Mexico insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 18 Mexico Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 19 Europe insulin pump market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 21 Europe insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 22 Europe Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 23 UK Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 24 UK insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 25 UK Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 26 Germany Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 27 Germany insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 28 Germany Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 29 France Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 30 France insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 31 France Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 32 Italy Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 33 Italy insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 34 Italy Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 35 Spain Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 36 Spain insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 37 Spain Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 38 Norway Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 39 Norway insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 40 Norway Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 41 Sweden Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 42 Sweden insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 43 Sweden Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 44 Denmark Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 45 Denmark insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 46 Denmark Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific insulin pump market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 51 Japan Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 52 Japan insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 53 Japan Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 54 China Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 55 China insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 56 China Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 57 India Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 58 India insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 59 India Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 60 Australia Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 61 Australia insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 62 Australia Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 63 South Korea Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 64 South Korea insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 65 South Korea Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 66 Thailand Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 67 Thailand insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 68 Thailand Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 69 Latin America insulin pump market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 71 Latin America insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 72 Latin America Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 73 Brazil Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 74 Brazil insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 75 Brazil Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 76 Argentina Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 77 Argentina insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 78 Argentina Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 79 Middle East & Africa insulin pump market, by country, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 83 South Africa Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 84 South Africa insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 85 South Africa Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 89 UAE Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 90 UAE insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 91 UAE Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Insulin Pump Market, By Product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait insulin pump market, by system architecture, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Insulin Pump Market, By End-use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Insulin pump market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Insulin pump market, product outlook key takeaways (USD Million)
  • Fig. 12 Insulin pump market product movement analysis (USD Million), 2025 & 2033
  • Fig. 13 Tubed pump market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Tubeless insulin pump market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Insulin pump market, system architecture outlook key takeaways (USD Million)
  • Fig. 16 Insulin pump market system architecture movement analysis (USD Million), 2025 & 2033
  • Fig. 17 Open-loop systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Closed-loop systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Insulin pump market, end-use outlook key takeaways (USD Million)
  • Fig. 20 Insulin pump market end-use movement analysis (USD Million), 2025 & 2033
  • Fig. 21 Homecare market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Hospitals & care providers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Insulin pump market: Regional key takeaways (USD Million)
  • Fig. 24 Insulin pump market regional outlook, 2025 & 2033, USD Million
  • Fig. 25 North America insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 US insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Canada insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Mexico insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Europe insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 UK insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Germany insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 France insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Spain insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Italy insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Sweden insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Norway insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Denmark insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Asia Pacific insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 China insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Japan insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 India insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 South Korea insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Australia insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Thailand insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Latin America insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Brazil insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Argentina insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Middle East and Africa insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 South Africa insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Saudi Arabia insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 UAE insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Kuwait insulin pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 List of key emerging company's/indication disruptors/innovators